What is the expected growth forecast for the Neonate Bilirubin Phototherapy Equipment market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Neonate Bilirubin Phototherapy Equipment market?

Increasing demand for phototherapy equipment in hospitals drives the market.

What are the major challenges facing the Neonate Bilirubin Phototherapy Equipment market?

High equipment costs and lack of awareness hinder market growth.

Which regions are leading the Neonate Bilirubin Phototherapy Equipment market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Neonate Bilirubin Phototherapy Equipment market?

Top companies include Philips, GE Healthcare, and Natus Medical.

What future opportunities exist in the Neonate Bilirubin Phototherapy Equipment market?

Emerging economies and advancements in technology offer future opportunities.

How does technology impact the Neonate Bilirubin Phototherapy Equipment market?

Advances in LED technology improve treatment efficacy and reduce costs.

What is the current regulatory landscape for the Neonate Bilirubin Phototherapy Equipment market?

Regulations vary by region, with FDA and CE markings required in the US and EU.

Neonate Bilirubin Phototherapy Equipment Growth Analysis & Future Outlook 2033

Neonate Bilirubin Phototherapy Equipment by Application (Hospitals, Confinement Centers, Others), by Types (Contact Type, Contactless Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 100

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Neonate Bilirubin Phototherapy Equipment Market Overview

The Neonate Bilirubin Phototherapy Equipment market refers to the global industry that provides medical devices used to treat neonatal jaundice. As a critical component of neonatal care, the Neonate Bilirubin Phototherapy Equipment market size is expected to witness significant growth, driven by the increasing prevalence of neonatal jaundice and the growing demand for effective treatment options. The growth outlook for the market is promising, with a market forecast that indicates a steady rise in revenue over the forecast period. The industry expansion is expected to be driven by advancements in technology, increasing awareness about the importance of neonatal care, and the rising demand for phototherapy equipment in developing regions.

Loading chart…

The current Neonate Bilirubin Phototherapy Equipment market size is approximately $340 million, with a growth forecast that indicates a compound annual growth rate (CAGR) of 5.5% over the forecast period. The largest region in the market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for neonatal care and the rising prevalence of neonatal jaundice. Key forces shaping the industry include technology shifts, such as the development of more efficient and cost-effective phototherapy equipment, regulations that govern the safety and efficacy of medical devices, and consumer behavior, which is driving the demand for more convenient and user-friendly treatment options. Other macro drivers, such as competitive intensity and supply-chain dynamics, are also expected to play a significant role in shaping the industry over the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	2.19 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Weyer GmbH; Delta Medical International; Natus Medical Incorporated; Medicor; Drager; Zeal Medical; MTTS; David Medical Device; BEING MEDICAL DEVICE; BIOBASE; Julongsanyou Technology; Phoenix Medical Systems; Ibis Medical; Apothecaries Sundries Manufacturing
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Neonate Bilirubin Phototherapy Equipment market is experiencing significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that impact the Neonate Bilirubin Phototherapy Equipment market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of neonatal jaundice is driving the demand for Neonate Bilirubin Phototherapy Equipment, particularly in developing countries with limited access to healthcare services.

Advances in phototherapy technology, such as the development of more efficient and portable devices, are expanding the Neonate Bilirubin Phototherapy Equipment market and improving treatment outcomes.

Restraints2 items

High costs associated with Neonate Bilirubin Phototherapy Equipment and limited reimbursement options in some countries are constraining market growth and limiting access to treatment.

Stringent regulatory requirements and safety standards for Neonate Bilirubin Phototherapy Equipment are creating barriers to entry for new manufacturers and increasing the burden on existing players.

Opportunities2 items

Emerging markets in Asia and Latin America offer significant opportunities for growth in the Neonate Bilirubin Phototherapy Equipment market, driven by increasing demand for healthcare services and improving economic conditions.

The development of innovative, cost-effective Neonate Bilirubin Phototherapy Equipment solutions is expected to drive market expansion and increase access to treatment in resource-constrained settings.

Challenges2 items

The Neonate Bilirubin Phototherapy Equipment market is highly competitive, with several established players competing for market share, which can make it challenging for new entrants to establish themselves.

Ensuring the safety and efficacy of Neonate Bilirubin Phototherapy Equipment is a significant challenge, particularly in low-resource settings where maintenance and repair services may be limited, impacting the overall growth forecast.

Market Segmentation

Loading chart…

The Neonate Bilirubin Phototherapy Equipment segmentation by application refers to the different uses of phototherapy equipment in treating neonatal jaundice. This market can be segmented into various applications, including hospital treatment, clinic treatment, and home treatment. Each application contributes to the overall market size, with hospital treatment being the largest segment due to the high demand for phototherapy equipment in hospitals.

The Neonate Bilirubin Phototherapy Equipment market can also be segmented by types, which include conventional phototherapy, fiber-optic phototherapy, and light-emitting diode (LED) phototherapy. Each type has its own set of advantages and disadvantages, and the choice of type depends on the specific needs of the patient and the healthcare provider. The market taxonomy of these types is crucial in understanding the overall market size and trends.

Neonate Bilirubin Phototherapy Equipment Segmentation Breakdown7 items

Application

Hospitals

Confinement Centers

Others

Types

Contact Type

Contactless Type

Regional Insights

Loading chart…

The Neonate Bilirubin Phototherapy Equipment market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and also the fastest-growing region, driven by increasing adoption of advanced phototherapy equipment, favorable policies, and significant investments in healthcare infrastructure. Key drivers for Asia Pacific include rising demographics, improving infrastructure, and growing ecosystem maturity.

In North America, key drivers include high adoption rates, stringent policies and regulations, and significant investments in research and development. Europe is driven by increasing demographics, favorable policies, and a mature ecosystem. Latin America and Middle East & Africa are driven by growing infrastructure, increasing adoption, and improving ecosystem maturity. The regional forecast indicates a positive outlook for the Neonate Bilirubin Phototherapy Equipment market, with Asia Pacific leading the way.

Competitive Landscape

The Neonate Bilirubin Phototherapy Equipment market is moderately consolidated, driven by a mix of global players and local companies. The Neonate Bilirubin Phototherapy Equipment competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies concentrate on pricing and distribution.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. They also focus on technology, service model, channel strength, customization, and cost advantages to differentiate their products. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players in the market include:

GE Healthcare: regional expansion

Weyer GmbH: premium pricing

Delta Medical International: OEM tie-ups

Natus Medical Incorporated: innovation pipeline

Medicor: local manufacturing

Drager: vertical integration

Key Neonate Bilirubin Phototherapy Equipment Companies15 items

GE Healthcare

Weyer GmbH

Delta Medical International

Natus Medical Incorporated

Medicor

Drager

Zeal Medical

MTTS

David Medical Device

BEING MEDICAL DEVICE

BIOBASE

Julongsanyou Technology

Phoenix Medical Systems

Ibis Medical

Apothecaries Sundries Manufacturing

Market Ecosystem

The Neonate Bilirubin Phototherapy Equipment ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and manufacturers, to downstream channels and end users. This ecosystem is characterized by the creation and capture of value through the development, production, and distribution of phototherapy equipment for treating neonatal jaundice. The boundaries of this ecosystem are defined by the interactions among these participants, influencing the flow of value and the overall efficiency of the ecosystem.

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and producing equipment

Technology providers — developing underlying technologies

System integrators / EPCs — integrating equipment into healthcare settings

Distributors / channel partners — delivering equipment to end users

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing safety and efficacy standards

In the Neonate Bilirubin Phototherapy Equipment ecosystem, control points are largely influenced by regulators and standards bodies, as well as by technology providers who drive innovation. Dependency risks arise from input constraints, such as the availability of critical components, and from the need for approvals and compliance with established standards. Switching costs and interoperability requirements also play a significant role, as end users often prefer equipment that can integrate seamlessly with existing healthcare infrastructure. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and healthcare infrastructure, highlighting the need for a nuanced understanding of the ecosystem through a detailed value chain analysis.

Recent Industry Insights

The Neonate Bilirubin Phototherapy Equipment industry trends have witnessed significant developments over the last 12-18 months. Recently, there have been notable partnerships, such as collaborations between leading medical device manufacturers and healthcare providers, to enhance the accessibility and affordability of phototherapy equipment. Additionally, the industry has seen strategic mergers and acquisitions, aiming to expand product portfolios and strengthen market presence.

Furthermore, several companies have launched innovative products and technologies, focusing on improved efficacy, safety, and user experience. Regulatory changes have also played a crucial role in shaping the industry, with updated guidelines and standards for the development and use of phototherapy equipment. These developments have contributed to a shift in consumer and enterprise trends, with a growing emphasis on personalized and home-based care solutions. The industry is expected to continue evolving, driven by funding rounds, expansions, and advancements in technology.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Neonate Bilirubin Phototherapy Equipment market outlook. The market attractiveness is moderate, driven by the increasing prevalence of neonatal jaundice and the rising demand for non-invasive treatments. The competitive intensity is high, with key players competing based on product innovation and pricing strategies. The long-term outlook is positive, with the market expected to grow due to advancements in phototherapy technology and increasing awareness about the importance of early treatment.

The innovation landscape is evolving, with a focus on developing more efficient and portable devices. However, the demand-supply balance is a key risk factor, as supply chain disruptions can impact the availability of equipment. Overall, decision-makers should be aware of these factors to navigate the complex Neonate Bilirubin Phototherapy Equipment market and make informed decisions.

11 items

1. Executive Summary

2. Neonate Bilirubin Phototherapy Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Neonate Bilirubin Phototherapy Equipment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Neonate Bilirubin Phototherapy Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Confinement Centers

6.1.3. Others

6.2. Global Neonate Bilirubin Phototherapy Equipment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Contact Type

6.2.2. Contactless Type

6.3. Global Neonate Bilirubin Phototherapy Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Neonate Bilirubin Phototherapy Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Neonate Bilirubin Phototherapy Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Neonate Bilirubin Phototherapy Equipment Market Competition by Key Manufacturers

8.1. Global Neonate Bilirubin Phototherapy Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Neonate Bilirubin Phototherapy Equipment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GE Healthcare

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Weyer GmbH

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Delta Medical International

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Natus Medical Incorporated

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Medicor

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Drager

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Zeal Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. MTTS

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. David Medical Device

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BEING MEDICAL DEVICE

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BIOBASE

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Julongsanyou Technology

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Phoenix Medical Systems

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Ibis Medical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Apothecaries Sundries Manufacturing

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Neonate Bilirubin Phototherapy Equipment Market

Figure 4: Global Neonate Bilirubin Phototherapy Equipment Market: Drivers

Figure 5: Global Neonate Bilirubin Phototherapy Equipment Market: Challenges

Figure 6: Global Neonate Bilirubin Phototherapy Equipment Market: Trends

Figure 7: Global Neonate Bilirubin Phototherapy Equipment Market: Opportunity

Figure 8: Global Neonate Bilirubin Phototherapy Equipment Market: Restraint

Figure 9: Global Neonate Bilirubin Phototherapy Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Neonate Bilirubin Phototherapy Equipment Market Value (USD Million) By Region

Figure 15: Global Neonate Bilirubin Phototherapy Equipment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Neonate Bilirubin Phototherapy Equipment Market Value (USD Million) By Region

Figure 23: Global Neonate Bilirubin Phototherapy Equipment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Neonate Bilirubin Phototherapy Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Neonate Bilirubin Phototherapy Equipment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Neonate Bilirubin Phototherapy Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Neonate Bilirubin Phototherapy Equipment Market Value (USD Million) By Region

Table 10: Global Neonate Bilirubin Phototherapy Equipment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Neonate Bilirubin Phototherapy Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Neonate Bilirubin Phototherapy Equipment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Neonate Bilirubin Phototherapy Equipment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GE Healthcare Basic Information And Sales Area

Table 31: GE Healthcare. Products Portfolio

Table 32: Weyer GmbH Basic Information And Sales Area

Table 33: Weyer GmbH. Products Portfolio

Table 34: Delta Medical International Basic Information And Sales Area

Table 35: Delta Medical International. Products Portfolio

Table 36: Natus Medical Incorporated Basic Information And Sales Area

Table 37: Natus Medical Incorporated. Products Portfolio

Table 38: Medicor Basic Information And Sales Area

Table 39: Medicor. Products Portfolio

Table 40: Drager Basic Information And Sales Area

Table 41: Drager. Products Portfolio

Table 42: Zeal Medical Basic Information And Sales Area

Table 43: Zeal Medical. Products Portfolio

Table 44: MTTS Basic Information And Sales Area

Table 45: MTTS. Products Portfolio

Table 46: David Medical Device Basic Information And Sales Area

Table 47: David Medical Device. Products Portfolio

Table 48: BEING MEDICAL DEVICE Basic Information And Sales Area

Table 49: BEING MEDICAL DEVICE. Products Portfolio

Table 50: BIOBASE Basic Information And Sales Area

Table 51: BIOBASE. Products Portfolio

Table 52: Julongsanyou Technology Basic Information And Sales Area

Table 53: Julongsanyou Technology. Products Portfolio

Table 54: Phoenix Medical Systems Basic Information And Sales Area

Table 55: Phoenix Medical Systems. Products Portfolio

Table 56: Ibis Medical Basic Information And Sales Area

Table 57: Ibis Medical. Products Portfolio

Table 58: Apothecaries Sundries Manufacturing Basic Information And Sales Area

Table 59: Apothecaries Sundries Manufacturing. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Neonate Bilirubin Phototherapy Equipment Market Value (USD Million) By Region

Table 65: Global Neonate Bilirubin Phototherapy Equipment Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Neonate Bilirubin Phototherapy Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	2.19 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GE Healthcare; Weyer GmbH; Delta Medical International; Natus Medical Incorporated; Medicor; Drager; Zeal Medical; MTTS; David Medical Device; BEING MEDICAL DEVICE; BIOBASE; Julongsanyou Technology; Phoenix Medical Systems; Ibis Medical; Apothecaries Sundries Manufacturing
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing prevalence of neonatal jaundice is driving the demand for Neonate Bilirubin Phototherapy Equipment, particularly in developing countries with limited access to healthcare services.

Restraints2 items

High costs associated with Neonate Bilirubin Phototherapy Equipment and limited reimbursement options in some countries are constraining market growth and limiting access to treatment.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Neonate Bilirubin Phototherapy Equipment Segmentation Breakdown7 items

Application

Hospitals

Confinement Centers

Others

Types

Contact Type

Contactless Type

Regional Insights

Loading chart…

Competitive Landscape

GE Healthcare: regional expansion

Weyer GmbH: premium pricing

Delta Medical International: OEM tie-ups

Natus Medical Incorporated: innovation pipeline

Medicor: local manufacturing

Drager: vertical integration

Key Neonate Bilirubin Phototherapy Equipment Companies15 items

GE Healthcare

Weyer GmbH

Delta Medical International

Natus Medical Incorporated

Medicor

Drager

Zeal Medical

MTTS

David Medical Device

BEING MEDICAL DEVICE

BIOBASE

Julongsanyou Technology

Phoenix Medical Systems

Ibis Medical

Apothecaries Sundries Manufacturing

Market Ecosystem

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and producing equipment

Technology providers — developing underlying technologies

System integrators / EPCs — integrating equipment into healthcare settings

Distributors / channel partners — delivering equipment to end users

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents